Emergent BioSolutions
EBS
#6749
Rank
ยฃ0.49 B
Marketcap
ยฃ9.20
Share price
-4.40%
Change (1 day)
19.30%
Change (1 year)

Emergent BioSolutions (EBS) - P/B ratio

P/B ratio as of January 2026 : 1.13

According to Emergent BioSolutions 's latest financial reports the company has a price-to-book ratio of 0.880538.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Emergent BioSolutions - P/B ratio (from 2006 to 2025)

P/B ratio by year

Year P/B ratio Change
2025-12-311.1422.66%
2024-12-310.9281383.96%
2023-12-310.1918-54.83%
2022-12-310.4246-70.74%
2021-12-311.45-55.78%
2020-12-313.2828.07%
2019-12-312.56-14.65%
2018-12-313.0018.13%
2017-12-312.5413.93%
2016-12-312.23-6.62%
2015-12-312.3928.7%
2014-12-311.867.84%
2013-12-311.7232.27%
2012-12-311.30-10.43%
2011-12-311.45-33.92%
2010-12-312.2027.95%
2009-12-311.72-56.15%
2008-12-313.92345.58%
2007-12-310.8795-60.46%
2006-12-312.22
2005-12-31N/A
2004-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Merck
MRK
5.25 363.01%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
2.32 104.38%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
4.81 323.80%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
2.85 151.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
1.54 36.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
5.19 357.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Soligenix
SNGX
1.82 60.26%๐Ÿ‡บ๐Ÿ‡ธ USA